Overview

A Study Comparing the Efficacy of Intravenous Followed by Oral Itraconazole With Intravenous Caspofungin For Empiric Antifungal Therapy in Neutropenic Participants With Hematological Malignancy

Status:
Terminated

Trial end date:
2018-05-02

Target enrollment:

Participant gender:

Summary

The purpose of this study is to investigate the hypothesis that the efficacy of intravenous (IV) itraconazole followed by oral itraconazole is non-inferior to that of intravenous caspofungin as empiric therapy for suspected fungal infection participants with fever and neutropenia.

Phase:

Phase 4

Details

Lead Sponsor:

Xian-Janssen Pharmaceutical Ltd.

Treatments:

Antifungal Agents
Caspofungin
Echinocandins
Hydroxyitraconazole
Itraconazole
Miconazole